These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 1813790

  • 1. Renal osteodystrophy in dialyzed children.
    Salusky IB, Goodman WG.
    Miner Electrolyte Metab; 1991; 17(4):273-80. PubMed ID: 1813790
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis.
    Salusky IB, Goodman WG.
    Child Nephrol Urol; 1991; 11(3):165-8. PubMed ID: 1777895
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
    Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB.
    Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H, Pańiczyk-Tomaszewska M, Debiński A, Polowiec Z, Sawicki A, Sieniawska M.
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral and aluminum concentrations in patients undergoing CAPD.
    Giangrande A, Costanini S, Ballanti P, Castiglioni A, Caligara F, Pisoni B, Giordano R, Vernillo I, Berni S, Bonucci E.
    Adv Perit Dial; 1992 Jun; 8():351-5. PubMed ID: 1361821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vitamin D therapy in CAPD: what is its role?
    Hutchison AJ, Gokal R.
    Adv Perit Dial; 1993 Jun; 9():253-6. PubMed ID: 8105937
    [Abstract] [Full Text] [Related]

  • 11. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
    Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG.
    Kidney Int; 1994 Jan; 45(1):253-8. PubMed ID: 8127016
    [Abstract] [Full Text] [Related]

  • 12. Renal osteodystrophy in CAPD.
    Hutchison AJ, Freemont AJ, Lumb GA, Gokal R.
    Adv Perit Dial; 1991 Jan; 7():237-9. PubMed ID: 1680434
    [Abstract] [Full Text] [Related]

  • 13. Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol.
    Juergensen PH, Finkelstein FO, Cooper K, Santacroce S, Kliger AS.
    Adv Perit Dial; 1993 Jan; 9():257-9. PubMed ID: 8105938
    [Abstract] [Full Text] [Related]

  • 14. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P.
    Scand J Urol Nephrol Suppl; 1984 Jan; 84():1-68. PubMed ID: 6393322
    [Abstract] [Full Text] [Related]

  • 15. Consequences of intermittent calcitriol therapy in pediatric patients with secondary hyperparathyroidism.
    Salusky IB, Goodman WG, Kuizon BD.
    Perit Dial Int; 1999 Jan; 19 Suppl 2():S441-4. PubMed ID: 10406561
    [No Abstract] [Full Text] [Related]

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 17. Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
    Chan HW, Tsang WK, Chan CM, Fung SK, So SO, Tang HL, Tong MK, Lee KC, Chan AY.
    Perit Dial Int; 1998 Nov; 18(2):177-82. PubMed ID: 9576366
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and management of bone disorders in chronic renal failure and dialyzed patients.
    Tzamaloukas AH.
    Med Clin North Am; 1990 Jul; 74(4):961-74. PubMed ID: 2195265
    [Abstract] [Full Text] [Related]

  • 19. Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients.
    Juergensen P, Santacroce S, Mooraki A, Cooper K, Finkelstein FO, Kliger AS.
    Adv Perit Dial; 1994 Jul; 10():259-60. PubMed ID: 7999840
    [Abstract] [Full Text] [Related]

  • 20. Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.
    Salusky IB, Kuizon BD, Belin TR, Ramirez JA, Gales B, Segre GV, Goodman WG.
    Kidney Int; 1998 Sep; 54(3):907-14. PubMed ID: 9734615
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.